Eye drops before surgery may tame inflammation in retinal detachment

NCT ID NCT07162818

First seen Jun 26, 2026 ยท Last updated Jun 26, 2026

Summary

This study tested whether nepafenac 0.1% eye drops, given before surgery, can lower inflammation in people with retinal detachment. Sixty-one adults used the drops or a placebo for five days before surgery. Researchers measured inflammatory markers in the eye fluid. The goal is to see if this simple treatment could help prevent a complication called proliferative vitreoretinopathy (PVR), which can cause surgical failure.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Nepafenac 0.1% eye drops
What this could lead to
If it works, this could point toward a simple eye drop treatment before surgery to reduce inflammation and prevent scarring in retinal detachment.
What could go wrong
This is a small, early-phase study measuring biomarkers, not clinical outcomes. The drops may not actually prevent vision loss or scarring in real-world use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROLIFERATIVE VITREORETINOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Ophthalmology, Faculty of Medicine Universitas Indonesia Cipto Mangunkusumo Hospital

    Jakarta, Jakarta Pusat, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.